PJ LOEHRER, LH EINHORN - Annals of Internal Medicine, 1984 - Am Coll Physicians Cisplatin is a metal coordination compound that was approved for clinical use in
treating testicular cancer 5 years ago. Although early trials showed marked
gastrointestinal and renal toxicities, treatment-related morbidity has been ... Cited by 208 - Related articles
PA Andrews, SB Howell - Cancer cells (Cold Spring Harbor, NY: 1989), 1990 - ncbi.nlm.nih.gov The interactions of cisplatin with DNA have been defined in sophisticated
detail; however, the interactions of this drug with other components of the cell
are less well understood. There is much interest in how cisplatin gets into ... Cited by 363 - Related articles
B Rosenberg - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 331 - Related articles - All 4 versions
A Eastman, N Schulte - Biochemistry, 1988 - ncbi.nlm.nih.gov Murine leukemia L1210 cells, either sensitive or resistant to the toxic action
of the cancer chemotherapeutic agent cis-diamminedichloroplatinum(II), have been
studied for potential differences in the formation and repair of ... Cited by 227 - Related articles - All 4 versions
- ►jcojournal.org [PDF] PA Reece, I Stafford, J Russell, PG Gill - Journal of Clinical Oncology, 1986 - jcojournal.org Reduced Ability to Clear Ultrafilterable Platinum With Repeated Courses of
Cisplatin ... By Phillip A. Reece, Irene Stafford, Jack Russell, and P.
Grantley Gill ... Ultrafilterable plasma and urinary levels of platinum ... Cited by 28 - Related articles - All 5 versions
R Becher, P Schütt, R Osieka, CG Schmidt - Journal of Cancer Research and Clinical Oncology, 1980 - Springer R. Becher, P. Schfitt 1, R. Osieka, and CG Schmidt Innere Universit~its- und
Poliklinik (Tumorforschung) 1 Neurologische Universitg_tsklinik, Westdeutsches
Tumorzentrum, Hufelandstr. 55, D-4300 Essen 1, Federal Republic of Germany Cited by 33 - Related articles - All 2 versions
- ►aacrjournals.org [PDF] VM Richon, N Schulte, A Eastman - Cancer Research, 1987 - AACR ABSTRACT As an experimental model for resistance to ciVdiamminedichloro-
platinum(II) (</\-l)!)!'). murine leukemia LI210 cells have been exposed to a
stepwise increase in c/s-DDP concentration to produce a variety of ... Cited by 138 - Related articles - All 3 versions
RF Ozols - Seminars in oncology, 1999 - ncbi.nlm.nih.gov Prospective randomized trials have established carboplatin plus paclitaxel as
the preferred combination chemotherapy for patients with advanced ovarian
cancer. However, clinical issues remain to be determined regarding the use ... Cited by 331 - Related articles - BL Direct - All 5 versions
- ►aacrjournals.org [PDF] BC Behrens, TC Hamilton, H Masuda, KR … - Cancer Research, 1987 - AACR Brent C. Bohrens, ' Thomas C. Hamilton, Hidetaka Masuda, Karen R. Grotzinger,
Jacqueline Whang-Peng, Karen G. Louie, Turid Knutsen, Wilma M. McKoy, Robert C.
Young, and Robert F. Ozols3 ... Medicine Branch, Division of Cancer ... Cited by 254 - Related articles - All 3 versions
